Back to Dashboard
CVRX · Healthcare

CVRX INC

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
26
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
◆ Next steps Interested in CVRX INC? Here's what to do with it.
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$129M
Industry
Medical Devices
Sector
Healthcare
Exchange
NasdaqGS
About CVRX INC

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales…

Who's behind the signal
Every informed buyer we can see on CVRX, across all three feeds.
Hedge funds · 5
Point72 (Steve Cohen) New position
D.E. Shaw & Co Increased +26%
Citadel Advisors Increased +563%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. CVRX INC isn't in the top-10 model right now, but 5 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
5
Investors
1
New positions
3
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.2×
Increased +25%
% of portfolio
0.0%
Position change
+25%
0.0% of Tudor Investment's portfolio
Trust weight: 1.0×
Increased +26%
% of portfolio
0.0%
Position change
+26%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
Increased +563%
% of portfolio
0.0%
Position change
+563%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
Decreased −39%
% of portfolio
0.0%
Position change
−39%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to CVRX INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell CVRX INC or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime